https://www.aigom.it/wp-content/uploads/2025/02/Screenshot-2025-02-04-102819.png791564Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-02-04 09:29:352025-02-04 09:29:35AIGOM PROGETTO CANOA 2025-CARCINOMA MAMMARIO: QUALI NOVITA’ NEL 2025?
https://www.aigom.it/wp-content/uploads/2025/02/ART.04.02.png1254960Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2025-02-03 09:18:082025-02-03 09:18:08CEMIPLIMAB PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN NON-SMALL CELL LUNG CANCER WITH PD-L1≥ 1 %: A SUBGROUP ANALYSIS FROM THE EMPOWER-LUNG 3 PART 2 TRIAL.
